MAYNARD RYAN D (Chief Financial Officer) sold 40.7% of their position (5.49K shares) of TVARDI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2024ACC: 0001415889-24-003404
Officer· Chief Financial Officer
Since Sep 2022
-5.49K
Net shares
Net seller
$2.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.49K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.49K
Price / share
$0.53
Trade value
$2.91K
% of position
40.7%
2/8/2023
13.50K→8.01K
Total
Net shares
−5.49K
Net value
-$2.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/8/2023 | S · Sale | −5.49K | $0.53 | $2.91K | 40.7% | 13.50K | 8.01K |
| Total | −5.49K | -$2.91K | ||||||
Derivative Transactions0
No derivative transactions reported